C

Cibus Inc
NASDAQ:CBUS

Watchlist Manager
Cibus Inc
NASDAQ:CBUS
Watchlist
Price: 1.66 USD -1.78% Market Closed
Market Cap: 90.1m USD

CBUS's latest stock split occurred on Jun 1, 2023

The company executed a 1-for-5 stock split, meaning that for every 5 shares held, investors received 1 new share.

Before the split, CBUS traded at 6.3 per share. Afterward, the share price was about 26.05.

The adjusted shares began trading on Jun 1, 2023. This was CBUS's 2nd stock split, following the previous one in Apr 25, 2023.

Last Splits:
Jun 1, 2023
1-for-5
Apr 25, 2023
1-for-10
Pre-Split Price
31.5 6.3
Post-Split Price
26.05
Before
After
Last Splits:
Jun 1, 2023
1-for-5
Apr 25, 2023
1-for-10

Cibus Inc
Stock Splits History

CBUS Stock Splits Timeline
Jun 1, 2023
Jun 1, 2023
Split 1-for-5
/0.2
Pre-Split Price
31.5 6.3
Post-Split Price
26.05
Before
After
Apr 25, 2023
Apr 25, 2023
Split 1-for-10
/0.1
Pre-Split Price
17.45 0.349
Post-Split Price
14.915
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Dec 29, 2025
Ise Chemicals Corp
OTC:ICHMF
10-for-1
x10
32.808 32.808 USD N/A
Dec 29, 2025
Bridgestone Corp
OTC:BRDCF
2-for-1
x2
45.22 45.22 USD N/A
Dec 29, 2025
Ibiden Co Ltd
OTC:IBIDF
2-for-1
x2
81 81 USD N/A
Dec 29, 2025
Itochu Corp
OTC:ITOCF
5-for-1
x5
62.79 62.79 USD N/A
Dec 29, 2025
Sumitomo Realty & Development Co Ltd
OTC:SURDF
2-for-1
x2
47.945 47.945 USD N/A
Load More

Cibus Inc
Glance View

Market Cap
87.1m USD
Industry
Biotechnology

Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. The company is headquartered in San Diego, California and currently employs 228 full-time employees. The company went IPO on 2017-07-20. The firm is engaged in developing and licensing plant traits to seed companies for royalties on seed sales. The firm is involved in gene-edited trait development, where plant traits (or specific genetic characteristics) that are indistinguishable from traits developed using traditional breeding are created using gene editing. Its patented RTDS technology platform includes the Trait Machine, which is a semi-automated stand-alone trait production facility. The Company’s Trait Machine materially changes the speed, breadth, and scale of trait development. The company is focused on the development of productivity traits and sustainable ingredients. The firm focuses on developing traits for addressing the sustainability challenges presented by climate change, disease, and pests.

CBUS Intrinsic Value
HIDDEN
Show
Back to Top